Every year, Pfizer sends an army of lobbyists to Washington, D.C., seeking to manipulate the tax code to their benefit.

It’s Tax Day, which, for most Americans, means it’s time to fork over lots of cash to the feds.

Unless you’re running Pfizer, which is paying a grand total of zero dollars and zero cents in taxes this year. In fact, Pfizer is expecting a hefty refund!

Despite bringing in $58 billion in revenue and billions in net income for 2023, Pfizer is not paying a dime in taxes. Thanks to their scale, size, and taxpayer-funded support system, Pfizer and its peers reap tax benefits that allow for the zeroing out of their tax burden. Such privileges are not afforded to Main Street businesses, highlighting an incredibly unequal tax code that benefits mega corporations at the expense of the average citizen and small businesses.

The news is especially unsavory for American taxpayers, considering the fact that Pfizer’s income over the course of the Covid era was produced via the American and overseas taxpayers themselves. Taxpayers subsidized the research and development, approval process, purchasing, and implementation of Pfizer’s junk mRNA product line. The mRNA shots, coupled with the failed Paxlovid oral pill, gave Pfizer an unprecedented windfall, delivering tens of billions in annual profits.